1. Home
  2. SUPN vs DNUT Comparison

SUPN vs DNUT Comparison

Compare SUPN & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • DNUT
  • Stock Information
  • Founded
  • SUPN 2005
  • DNUT 1937
  • Country
  • SUPN United States
  • DNUT United States
  • Employees
  • SUPN N/A
  • DNUT N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • DNUT Food Chains
  • Sector
  • SUPN Health Care
  • DNUT Consumer Staples
  • Exchange
  • SUPN Nasdaq
  • DNUT Nasdaq
  • Market Cap
  • SUPN 1.9B
  • DNUT 1.9B
  • IPO Year
  • SUPN 2012
  • DNUT 2021
  • Fundamental
  • Price
  • SUPN $36.60
  • DNUT $11.43
  • Analyst Decision
  • SUPN Hold
  • DNUT Buy
  • Analyst Count
  • SUPN 1
  • DNUT 9
  • Target Price
  • SUPN $36.00
  • DNUT $15.56
  • AVG Volume (30 Days)
  • SUPN 393.6K
  • DNUT 1.7M
  • Earning Date
  • SUPN 11-04-2024
  • DNUT 11-07-2024
  • Dividend Yield
  • SUPN N/A
  • DNUT 1.23%
  • EPS Growth
  • SUPN 130.79
  • DNUT N/A
  • EPS
  • SUPN 1.07
  • DNUT 0.16
  • Revenue
  • SUPN $651,972,000.00
  • DNUT $1,712,279,000.00
  • Revenue This Year
  • SUPN $4.01
  • DNUT $1.30
  • Revenue Next Year
  • SUPN $0.10
  • DNUT $6.44
  • P/E Ratio
  • SUPN $34.21
  • DNUT $69.35
  • Revenue Growth
  • SUPN 6.79
  • DNUT 4.42
  • 52 Week Low
  • SUPN $25.53
  • DNUT $9.18
  • 52 Week High
  • SUPN $39.37
  • DNUT $17.84
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 65.62
  • DNUT 48.57
  • Support Level
  • SUPN $33.43
  • DNUT $11.00
  • Resistance Level
  • SUPN $39.37
  • DNUT $12.68
  • Average True Range (ATR)
  • SUPN 1.42
  • DNUT 0.44
  • MACD
  • SUPN 0.25
  • DNUT 0.02
  • Stochastic Oscillator
  • SUPN 54.59
  • DNUT 25.30

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S., includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line; International includes operations in the U.K., Ireland, Australia, New Zealand, and Mexico; and Market Development includes franchise operations across the globe, as well as operations in Japan. It derives maximum revenue from U.S. Segment.

Share on Social Networks: